These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported||2008-005260-14||A double-blind placebo-controlled study of the safety, tolerability and efficacy of 12 months’ treatment with ACI 91 in patients with mild to moderate Alzheimer’s Disease||2012-01-17||due-trials|
|Exempt||2008-006257-40||A Phase I/II Double-Blind, Randomised, Placebo-Controlled, Adaptive Design Study of the Safety, Tolerability, Immunogenicity and Efficacy of ACI-24 in Patients with Mild to Moderate Alzheimer's Diseas...||2018-10-16||not-yet-due|
|Ongoing||2018-000445-39||A Phase II Double-Blind, Randomized, Placebo-Controlled, Adaptive Design Study to Assess the Safety, Tolerability, Immunogenicity and Target Engagement of ACI-24 Formulations in Patients with Mild Alz...||not-yet-due|